Aurobindo Pharma Annual Report 2022-23 -August 02, 2023 at 12 ... - Marketscreener.com
| PTKFF Stock | USD 0.1 0.00 0.00% |
Roughly 61% of PT Kalbe's investor base is looking to short. The analysis of overall sentiment of trading PT Kalbe Farma pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with PT Kalbe's historical and current headlines, can help investors time the market. In addition, many technical investors use PT Kalbe Farma stock news signals to limit their universe of possible portfolio assets.
PT Kalbe pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of PTKFF daily returns and investor perception about the current price of PT Kalbe Farma as well as its diversification or hedging effects on your existing portfolios.
PTKFF |
Aurobindo Pharma Annual Report 2022-23 -August 02, 2023 at 12 ... Marketscreener.com
Read at news.google.com
 |
PT Kalbe Fundamental Analysis
We analyze PT Kalbe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PT Kalbe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PT Kalbe based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
PT Kalbe is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
PT Kalbe Farma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PT Kalbe pink sheet to make a market-neutral strategy. Peer analysis of PT Kalbe could also be used in its relative valuation, which is a method of valuing PT Kalbe by comparing valuation metrics with similar companies.
Peers
PT Kalbe Related Equities
| GILD | Gilead Sciences | 0.95 | ||||
| NVS | Novartis | 0.26 | ||||
| AZN | AstraZeneca PLC | 0.06 | ||||
| BMY | Bristol Myers | 0.07 | ||||
| SNY | Sanofi ADR | 0.14 |
Complementary Tools for PTKFF Pink Sheet analysis
When running PT Kalbe's price analysis, check to measure PT Kalbe's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Kalbe is operating at the current time. Most of PT Kalbe's value examination focuses on studying past and present price action to predict the probability of PT Kalbe's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Kalbe's price. Additionally, you may evaluate how the addition of PT Kalbe to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |